» Articles » PMID: 25158076

Comparative Study of IgA VH 3 Gene Usage in Healthy TST(-) and TST(+) Population Exposed to Tuberculosis: Deep Sequencing Analysis

Overview
Journal Immunology
Date 2014 Aug 27
PMID 25158076
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The acquired immune response against tuberculosis is commonly associated with T-cell responses with little known about the role of B cells or antibodies. There have been suggestions that B cells and humoral immunity can modulate the immune response to Mycobacterium tuberculosis. However, the mechanisms involving B-cell responses in M. tuberculosis are not fully understood, in particular the antibody gene preferences. We hypothesized that a preferential use of V genes can be seen associated with resistance to infection mainly in the IgA isotype, which is of prominent importance for infection by pathogens via the mucosal route. We studied healthy individuals with long-term exposure to tuberculosis, infected (TST(+) ) and uninfected TST(-) ) with M. tuberculosis. From a total of 22 V genes analysed, the TST(-) population preferred the VH 3-23 and Vκ1 genes. The VH 3-23 genes were subsequently subjected to 454 amplicon sequencing. The TST(-) population showed a higher frequency of the D3-10 segment compared with the D3-22 segment for the TST(+) population. The J segment usage pattern was similar for both populations with J4 segment being used the most. A preferential pairing of J4 segments to D3-3 was seen for the TST(-) population. The antibodyome difference between both populations suggests a preference for antibodies with VH 3-23, D3-3, JH 4 gene usage by the TST(-) population that could be associated with resistance to infection with M. tuberculosis.

Citing Articles

PPE59 antibodies in tuberculous patients and potential use for diagnosis when assayed with other rapid biomarkers.

Mulinari A, Sardella I, da Silva V, Matteelli A, Carvalho A, Saad M Mem Inst Oswaldo Cruz. 2024; 119:e230183.

PMID: 39292107 PMC: 11404981. DOI: 10.1590/0074-02760230183.


Male Sex Bias in Immune Biomarkers for Tuberculosis.

Bothamley G Front Immunol. 2021; 12:640903.

PMID: 33796106 PMC: 8007857. DOI: 10.3389/fimmu.2021.640903.


B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis.

Rijnink W, Ottenhoff T, Joosten S Front Immunol. 2021; 12:640168.

PMID: 33679802 PMC: 7930078. DOI: 10.3389/fimmu.2021.640168.


Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Chin K, Sarmiento M, Alvarez-Cabrera N, Norazmi M, Acosta A Eur J Clin Microbiol Infect Dis. 2019; 39(5):799-826.

PMID: 31853742 PMC: 7222044. DOI: 10.1007/s10096-019-03771-0.


Changes in Transcript, Metabolite, and Antibody Reactivity During the Early Protective Immune Response in Humans to Mycobacterium tuberculosis Infection.

Weiner J, Domaszewska T, Donkor S, Kaufmann S, Hill P, Sutherland J Clin Infect Dis. 2019; 71(1):30-40.

PMID: 31412355 PMC: 7312225. DOI: 10.1093/cid/ciz785.


References
1.
Froyland M, Thompson K, Thorpe S, Sahota S, Gedde-Dahl T, Bogen B . A VH4-34+ myeloma protein with weak autoreactivity. Haematologica. 2007; 92(5):690-3. DOI: 10.3324/haematol.10850. View

2.
Arlehamn C, Sette A . Definition of CD4 Immunosignatures Associated with MTB. Front Immunol. 2014; 5:124. PMC: 3970006. DOI: 10.3389/fimmu.2014.00124. View

3.
Minassian A, Ronan E, Poyntz H, Hill A, McShane H . Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. PLoS One. 2011; 6(5):e19840. PMC: 3101220. DOI: 10.1371/journal.pone.0019840. View

4.
Abel L, El-Baghdadi J, Bousfiha A, Casanova J, Schurr E . Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1645):20130428. PMC: 4024222. DOI: 10.1098/rstb.2013.0428. View

5.
Reljic R, Williams A, Ivanyi J . Mucosal immunotherapy of tuberculosis: is there a value in passive IgA?. Tuberculosis (Edinb). 2006; 86(3-4):179-90. DOI: 10.1016/j.tube.2006.01.011. View